The Valley Desk

NCT02616965 · Interventional trial

A Study to Assess the Feasibility of Romidepsin Combined With Brentuximab Vedotin in Cutaneous T-cell Lymphoma

Overall registry status Completed

Phase 1

Conditions Cutaneous T-cell Lymphoma (CTCL)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov